Lipid signaling
Lipid signaling, broadly defined, refers to any biological
Sphingolipid second messengers
Ceramide
An increase in in vitro activity of acid SMase has been observed after applying multiple stress stimuli such as
Sphingosine
It is important to note that since sphingosine exerts
Sph is also known to interact with protein targets such as the
Sphingosine-1-Phosphate
S1P is probably formed at the inner leaflet of the plasma membrane in response to TNFα and other receptor activity-altering compounds called
The SK1-S1P pathway has been extensively studied in relation to cytokine action, with multiple functions connected to effects of
Glucosylceramide
In addition to their role as building blocks of biological membranes,
Ceramide-1-Phosphate
Ceramide-1-phosphate (C1P) is formed by the action of ceramide kinase (CK) enzymes on Cer. C1P carry ionic charge at neutral pH and contain two hydrophobic chains making it relatively insoluble in aqueous environment. Thus, C1P reside in the organelle where it was formed and is unlikely to spontaneously flip-flop across membrane bilayers.[31]
C1P activate
Phosphatidylinositol bisphosphate (PIP2) Lipid Agonist
PIP2 binds directly to ion channels and modulates their activity. PIP2 was shown to directly agonizes
Second messengers from phosphatidylinositol
Phosphatidylinositol bisphosphate (PIP2) Second Messenger Systems
A general second messenger system mechanism can be broken down into four steps. First, the agonist activates a membrane-bound receptor. Second, the activated G-protein produces a primary effector. Third, the primary effect stimulates the second messenger synthesis. Fourth, the second messenger activates a certain cellular process.
The
IP3 is soluble and diffuses freely into the cytoplasm. As a second messenger, it is recognized by the inositol triphosphate receptor (IP3R), a Ca2+ channel in the endoplasmic reticulum (ER) membrane, which stores intracellular Ca2+. The binding of IP3 to IP3R releases Ca2+ from the ER into the normally Ca2+-poor cytoplasm, which then triggers various events of Ca2+ signaling. Specifically in blood vessels, the increase in Ca2+ concentration from IP3 releases nitric oxide, which then diffuses into the smooth muscle tissue and causes relaxation.[34]
DAG remains bound to the membrane by its fatty acid "tails" where it recruits and activates both conventional and novel members of the protein kinase C family. Thus, both IP3 and DAG contribute to activation of PKCs.[60][61]
Activators of G-protein coupled receptors
See main article on
Lysophosphatidic acid (LPA)
Sphingosine-1-phosphate (S1P)
Platelet activating factor (PAF)
Endocannabinoids
The endogenous
Prostaglandins
FAHFA
FAHFAs (fatty acid esters of hydroxy fatty acids) are formed in adipose tissue, improve glucose tolerance and also reduce adipose tissue inflammation. Palmitic acid esters of hydroxy-stearic acids (PAHSAs) are among the most bioactive members able to activate
Retinol derivatives
Activators of nuclear receptors
See the main article on nuclear receptors
Steroid Hormones
This large and diverse class of
Retinoic acid
Prostaglandins
The majority of
See also
- Allostery
- Cell signaling
- Protein dynamics
- Lysophospholipid receptors
- List of signaling molecule types
References
- S2CID 19898617.
- S2CID 20973940.
- PMID 16229686.
- PMID 16170208.
- PMID 16905542.
- PMID 15883154.
- PMID 15052326.
- ^ Obeid, L. M., Linardic, C. M., Karolak, L. A. & Hannun, Y. A. (1993) Programmed cell death induced by ceramide. Science. 259, 1769–1771 .
- PMID 8530509.
- PMID 14657198.
- PMID 7877980.
- PMID 8662781.
- PMID 9094715.
- PMID 7744003.
- PMID 11723139.
- PMID 14739942.
- PMID 15901738.
- PMID 7634330.
- PMID 10722759.
- PMID 12578840.
- PMID 9632728.
- PMID 12960011.
- PMID 17339025.
- ^ PMID 15849201.
- S2CID 4406741.
- PMID 17591919.
- S2CID 8692993.
- PMID 16996023.
- PMID 12815058.
- PMID 1898331.
- ^ a b c d e f g h Hannun and Obeid (2008)
- PMID 12893264.
- PMID 11070884.
- ^ S2CID 10765956.
- PMID 17416206.
- PMID 9826677.
- ^ S2CID 8966010.
- S2CID 46727063.
- PMID 15158755.
- PMID 17050692.
- PMID 11443135.
- PMID 12069820.
- PMID 17280869.
- S2CID 22184217.
- S2CID 8617384.
- PMID 9695839.
- S2CID 4387982.
- ^ Radin, N. S., Shayman, J.A. & Inokuchi, J.-I. Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. Adv. Lipid Res. 26, 183–211
- PMID 17010304.
- PMID 8702646.
- PMID 9096129.
- PMID 17287460.
- PMID 14676210.
- PMID 14523050.
- PMID 12416995.
- PMID 15899891.
- S2CID 33693599.
- PMID 21874019.
- PMID 25633344.
- PMID 1318060.
- S2CID 31065063.
- PMID 25684574.
- PMID 25303528.
- PMID 27313314.
- PMID 18805086.